Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania
Tóm tắt
Identifying new approaches to tuberculosis treatment that are effective and put less demand to meagre health resources is important. One such approach is community based direct observed treatment (DOT). The purpose of the study was to determine the cost and cost effectiveness of health facility and community based directly observed treatment of tuberculosis in an urban setting in Tanzania. Two alternative strategies were compared: health facility based directly observed treatment by health personnel and community based directly observed treatment by treatment supervisors. Costs were analysed from the perspective of health services, patients and community in the year 2002 in US $ using standard methods. Treatment outcomes were obtained from a randomised-controlled trial which was conducted alongside the cost study. Smear positive, smear negative and extra-pulmonary TB patients were included. Cost-effectiveness was calculated as the cost per patient successfully treated. The total cost of treating a patient with conventional health facility based DOT and community based DOT were $ 145 and $ 94 respectively. Community based DOT reduced cost by 35%. Cost fell by 27% for health services and 72% for patients. When smear positive and smear negative patients were considered separately, community DOT was associated with 45% and 19% reduction of the costs respectively. Patients used about $ 43 to follow their medication to health facility which is equivalent to their monthly income. Indirect costs were as important as direct costs, contributing to about 49% of the total patient's cost. The main reason for reduced cost was fewer number of visits to the TB clinic. Community based DOT was more cost-effective at $ 128 per patient successfully treated compared to $ 203 for a patient successfully treated with health facility based DOT. Community based DOT presents an economically attractive option to complement health facility based DOT. This is particularly important in settings where TB clinics are working beyond capacity under limited resources.
Tài liệu tham khảo
Dye C, Scheale S, Dolin P, Pathania V, Raviglione MC: Global Burden of Tuberculosis: estimated incidence, prevelence and mortality by country. JAMA 1999, 282: 677–686. 10.1001/jama.282.7.677
Murray CJL, Styblo K, Rouillon A: Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis 1990, 65: 2–20.
Ministry of Health: Joint review of the National Tuberculosis and Leprosy Programme in Tanzania 2004. Dar es Salaam, Tanzania: Ministry of Health; 2004.
Ministry of Health: Health statistics abstract 2001. Dar Es Salaam, Tanzania: Ministry of Health; 2002.
World Bank: Country assistance strategy of the world bank group for the united republic of Tanzania, 2002. In Report 207228 TA. Dar es Salaam, Tanzania; 2002.
Wandwalo E, Kapalata N, Egwaga S, Morkve O: Effectiveness of community based directly observed treatment for tuberculosis in an urban setting in Tanzania: a randomised controlled trial. Int J Tuberc Lung Dis 2004, 8: 1248–1254.
Lwilla F, Schellenberg D, Masanja H, et al.: Evaluation of efficacy of community based vs. Institutional based direct observed short course treatment for the control of tuberculosis in Kilombero district, Tanzania. Tropical Medicine and International Health 2003, 8: 204–210. 10.1046/j.1365-3156.2003.00999.x
World Health Organisation: Community contribution to TB care: practice and policy. In WHO/CDS/TB/2003.312. Geneva, Switzerland: WHO; 2002.
Akkslip S, Rasmithat S, Maher , Sawert H: Direct observation of tuberculosis treatment by supervised family members in Yosothorn Province, Thailand. Int J Tuberc Lung Dis 1999, 3: 1061–1065.
Ministry of Health: Adult Morbidity and Mortality Project (AMMP). In End of phase 1 report. 1998. Dar es Salaam, Tanzania: Ministry of Health; 1998.
National Tuberculosis and Leprosy Programme: Manual for control of tuberculosis and leprosy in Tanzania. Dar es Salaam, Tanzania: Ministry of health; 2003.
Drummond MF, O'Brien B, Stoddart GL, Torrance GW: Methods for the economic evaluation of health care programme (2nd eds). Oxford, UK. Oxford University Press; 1997.
WHO: Guidelines for cost and cost effectiveness analysis of tuberculosis control. WHO/CDS/TB/2002.305a 2002.
Muennig P: Designing and conducting cost-effectiveness analysis in medicine and health care (1st eds). San Francisco, USA. John Wiley and sons; 2002.
Ministry of Health: Costing study of health services in Tanzania, 1999. Dar es Salaam, Tanzania: Ministry of Health; 1999.
Bank of Tanzania: Economic bulletin 2002. Dar es Salaam, Tanzania; 2003.
Zwarenstein M, Schoeman J, Vundule C, et al.: Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet 1998, 352: 1340–43. 10.1016/S0140-6736(98)04022-7
Dye C, Garnett GP, Sleeman K, Williams BG: Prospects for world-wide TB control under the WHO DOTS strategy. Lancet 1998, 352: 1886–1891. 10.1016/S0140-6736(98)03199-7
Range N, Ipuge YA, O'Brien RJ, Egwaga SM, et al.: Trend in HIV prevalence among tuberculosis patients in Tanzania, 1991–1998. Int J Tuberc Lung Dis 2001, 5: 405–412.
Murray CJM, DeJonghe E, Chum HJ, Nyangulu DS, Salomao A, Styblo K: Cost-effectiveness of chemotherapy for pulmonary TB in three sub-Saharan African countries. Lancet 1991, 338: 1305–1308. 10.1016/0140-6736(91)92600-7
World Bank: World Development Report 1993. Investing in health. New york. Oxford University Press; 1993.
Johannesson M, Karlsson G: The friction cost method: A comment. Journal of Health Economics 1997, 16: 249–255. 10.1016/S0167-6296(97)00006-4
Wyss K, Kilima P, Lorenz N: Cost of tuberculosis for households and health care providers in Dar es Salaam. Tropical Medicine and International Health 2001, 6: 60–68. 10.1046/j.1365-3156.2001.00677.x
Nedham DM, Godfrey-Faussett P, Foster SD: Barriers to tuberculosis control in urban Zambia: the economic impact and burden on patients prior to diagnosis. Int J Tuberc Lung Dis 1998,2(10):811–817.
Community TB care in Africa Int J Tuberc Lung Dis 2003,7(Supplement 1):S1-S102.
Floyd K, Skeva J, Nyirenda T, Gausi F, Salaniponi F: Cost and Cost-effectiveness of increased community and primary care facility involvelment in tuberculosis care in Lilongwe District, Malawi. Int J Tuberc Lung Dis 2003, 7: S29-S37.
Nganda B, Wang"ombe J, Floyd K, Kangangi J: Cost and Cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Machakos District, Kenya. Int J Tuberc Lung Dis 2003, 7: S14-S20.